📰 Bioscience Inc News
Page 7 - Bioscience Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bioscience Inc. Real-time updates on events, politics, business and more.
December 26, 2023
SAN DIEGO, Dec. 26, 2023 -- Daré Bioscience, Inc. , a leader in women’s health innovation, today announced it has entered into a royalty-backed financing agreement that provides Daré with $5...
December 22, 2023
PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.11 and traded as high as $0.15. PURE Bioscience shares last traded at $0.12, with a volume of 133,907 shares trading hands. PURE Bioscience Stock Performance The […]
December 20, 2023
SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. DARE, a leader in women's health innovation, today announced positive topline results from…
December 20, 2023
Daré Bioscience Inc DARE announced topline results from the Phase 1 DARE-PDM1-001 study evaluating the pharmacokinetics (PK), safety, and exploratory efficacy…
December 19, 2023
The Wall Street is headed to end 2023 on a strongly positive note as the Fed’s indication of coming rate cuts have infused a latest rally which isn’t abating despite several Fed officials saying the...
December 15, 2023
TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET Empire Manufacturing, Fed’s Williams speaks; 9:15ET Industrial Production, Capacity Utilization, Manufacturing Production; 9:45ET S&P Global US Manufacturing and Services PMIs TODAY’S HIGHLIGHTS: Detroit Pistons are on pace to be the worst NBA team of all timeGlobal coal use at all-time high
December 13, 2023
DARE-PTB1 is being developed as a treatment to reduce the risk of preterm birth, for which there are no FDA-approved treatment options Up to approximately $2 million in grant funding to support DARE-PTB1 Phase 1 human
December 13, 2023
INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 196,700 shares, a decline of 80.3% from the November 15th total of 997,200 shares. Based on an average daily volume of 3,830,000 shares, […]
December 7, 2023
Daré Bioscience Inc (NASDAQ: DARE) announced that the FDA has cleared its investigational new drug (IND) application for DARE-VVA1 as a non-hormonal treatment option for moderate to severe dyspareunia, a symptom of VVA 
December 7, 2023
Daré Bioscience Inc DARE announced that the FDA has cleared its investigational new drug (IND) application for DARE-VVA1 as a non-hormonal treatment option…